Skip to main content
Ipinapakita ang mga post na may etiketa na statins. Ipakita ang lahat ng mga post
Ipinapakita ang mga post na may etiketa na statins. Ipakita ang lahat ng mga post
Demonising cholesterol! What a mistake!

Demonising cholesterol! What a mistake!

This article in the Irish Times is good! At last, some voices on how wrong it is demonising cholesterol! Followers of this blog may remember this  related paper Lipids and cardiovascular disease: wh…

Chewing the fat over statins

Chewing the fat over statins

this is a very interesting paper that shows that there is sth wrong around statins prescription... Chewing the fat over statins: Consumer concerns about lipid-lowering medication Deckx, L. a Kreijkam…

statins: and the debate goes on

statins: and the debate goes on

the followers / readers of this blog have been across some info on the "dark" side of statins, i.e. the numerous and severe side-effects that statins have. Here is another report on this t…

Nocebo but not side effects of statins?

Nocebo but not side effects of statins?

This story is very UN-reliable... and the paper of very limited scope. However, the comments of the readers are Great and really spot on! Here are some really good ones   JENNIFER CARTER …

Statins and Declaration of Interests

Statins and Declaration of Interests

While writing my new book , I came across the following... Interpretation of the evidence for the efficacy and safety of statin therapy http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(16…

Statins and vested interests

Statins and vested interests

The debate on the value of statins gets hotter! In the heart of the debate are papers, claims and ...patents. In a recent paper, some interesting facts were published : a Sunday Times investigation …

Do We Need Books?

Do We Need Books?

Pixabay   Some views on the value of books are presented here. Many thanks to the Elsevier team for their hospitality! Ioannis

cardiovascular diseases: novel drug, old approach

cardiovascular diseases: novel drug, old approach

I read with interest the news on evolocumab and a large international trial on 27,000 patients. The British Heart Foundation said the findings were a significant advance in fighting the biggest kill…